Mas, L.; Lupinacci, R.M.; Cros, J.; Bachet, J.-B.; Coulet, F.; Svrcek, M.
Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights. Int. J. Mol. Sci. 2021, 22, 6756.
https://doi.org/10.3390/ijms22136756
AMA Style
Mas L, Lupinacci RM, Cros J, Bachet J-B, Coulet F, Svrcek M.
Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights. International Journal of Molecular Sciences. 2021; 22(13):6756.
https://doi.org/10.3390/ijms22136756
Chicago/Turabian Style
Mas, Léo, Renato M. Lupinacci, Jérôme Cros, Jean-Baptiste Bachet, Florence Coulet, and Magali Svrcek.
2021. "Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights" International Journal of Molecular Sciences 22, no. 13: 6756.
https://doi.org/10.3390/ijms22136756
APA Style
Mas, L., Lupinacci, R. M., Cros, J., Bachet, J.-B., Coulet, F., & Svrcek, M.
(2021). Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights. International Journal of Molecular Sciences, 22(13), 6756.
https://doi.org/10.3390/ijms22136756
